학술논문
Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib
Document Type
Article
Author
Source
In Blood 27 February 2014 123(9):1353-1360
Subject
Language
ISSN
0006-4971